These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 16287979)
1. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Jiang W; Sun R; Wei H; Tian Z Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17077-82. PubMed ID: 16287979 [TBL] [Abstract][Full Text] [Related]
2. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice. Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179 [TBL] [Abstract][Full Text] [Related]
3. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats. Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456 [TBL] [Abstract][Full Text] [Related]
4. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073 [TBL] [Abstract][Full Text] [Related]
5. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice. Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984 [TBL] [Abstract][Full Text] [Related]
6. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells. Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway. Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Mohammad MK; Morran M; Slotterbeck B; Leaman DW; Sun Y; Grafenstein Hv; Hong SC; McInerney MF Int Immunol; 2006 Jul; 18(7):1101-13. PubMed ID: 16728431 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Bachar O; Adner M; Uddman R; Cardell LO Eur J Immunol; 2004 Apr; 34(4):1196-207. PubMed ID: 15048731 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2. Lee HK; Yeo S; Kim JS; Lee JG; Bae YS; Lee C; Baek SH Mol Pharmacol; 2010 Sep; 78(3):478-85. PubMed ID: 20558593 [TBL] [Abstract][Full Text] [Related]
11. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice. Kang JW; Kim DW; Choi JS; Kim YS; Lee SM Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186 [TBL] [Abstract][Full Text] [Related]
12. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385 [TBL] [Abstract][Full Text] [Related]
14. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289 [TBL] [Abstract][Full Text] [Related]
15. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275 [TBL] [Abstract][Full Text] [Related]
16. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice. Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893 [TBL] [Abstract][Full Text] [Related]
17. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo. Fraser CK; Lousberg EL; Kumar R; Hughes TP; Diener KR; Hayball JD Exp Hematol; 2009 Dec; 37(12):1435-44. PubMed ID: 19786067 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173 [TBL] [Abstract][Full Text] [Related]
19. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Wu GJ; Chen TL; Ueng YF; Chen RM Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973 [TBL] [Abstract][Full Text] [Related]
20. Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure. Kitazawa T; Tsujimoto T; Kawaratani H; Fujimoto M; Fukui H J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e494-8. PubMed ID: 18070011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]